AFP and hepatocellular carcinoma: For all-stage hepatitis-related HCC vs. CH and LC, the ROC curves showed that the AFP/AFU combination had an AUC of 0.835 (95% CI: 0.784–0.877), a sensitivity of 69.1%, and a specificity of 87.4%.